Clinical trial
Does Intraoperatively Administered Methylprednisolone Prolong the Neuromuscular Blocade Reversal Effect of Sugammadex?
NCT02025309 is registered in ClinicalTrials.gov with Ankara University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Does Intraoperatively Administered Methylprednisolone Prolong the Neuromuscular Blocade Reversal Effect of Sugammadex?
- Lead sponsor
- Ankara University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 31, 2013
- Completion date
- May 31, 2014
- Enrollment
- 164 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
neuromuscular monitoring, sugammadex effect